Recent advances targeting CCR5 for cancer and its role in immuno-oncology

X Jiao, O Nawab, T Patel, AV Kossenkov… - Cancer …, 2019 - aacrjournals.org
Experiments of nature have revealed the peculiar importance of the G-protein–coupled
receptor, CC chemokine receptor type 5 (CCR5), in human disease since ancient times. The …

International union of pharmacology. XXII. Nomenclature for chemokine receptors

PM Murphy, M Baggiolini, IF Charo, CA Hébert… - Pharmacological …, 2000 - Elsevier
Chemokine receptors comprise a large family of seven transmembrane domain G protein-
coupled receptors differentially expressed in diverse cell types. Biological activities have …

[HTML][HTML] CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

BK Patterson, H Seethamraju, K Dhody… - International Journal of …, 2021 - Elsevier
Objective Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
now a global pandemic. Emerging results indicate a dysregulated immune response. Given …

Chemokine: receptor structure, interactions, and antagonism

SJ Allen, SE Crown, TM Handel - Annu. Rev. Immunol., 2007 - annualreviews.org
Chemokines are critical mediators of cell migration during routine immune surveillance,
inflammation, and development. Chemokines bind to G protein–coupled receptors and …

Opportunities for therapeutic antibodies directed at G-protein-coupled receptors

CJ Hutchings, M Koglin, WC Olson… - Nature reviews Drug …, 2017 - nature.com
G-protein-coupled receptors (GPCRs) are activated by a diverse range of ligands, from large
proteins and proteases to small peptides, metabolites, neurotransmitters and ions. They are …

Pharmacological modulation of chemokine receptor function

DJ Scholten, M Canals, D Maussang… - British journal of …, 2012 - Wiley Online Library
G protein‐coupled chemokine receptors and their peptidergic ligands are interesting
therapeutic targets due to their involvement in various immune‐related diseases, including …

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

T Dragic, A Trkola, DAD Thompson, EG Cormier… - Proceedings of the …, 2000 - pnas.org
HIV-1 entry into CD4+ cells requires the sequential interactions of the viral envelope
glycoproteins with CD4 and a coreceptor such as the chemokine receptors CCR5 and …

Structural analysis of chemokine receptor–ligand interactions

M Arimont, SL Sun, R Leurs, M Smit… - Journal of medicinal …, 2017 - ACS Publications
This review focuses on the construction and application of structural chemokine receptor
models for the elucidation of molecular determinants of chemokine receptor modulation and …

Production of pharmaceutical‐grade recombinant aprotinin and a monoclonal antibody product using plant‐based transient expression systems

GP Pogue, F Vojdani, KE Palmer, E Hiatt… - Plant biotechnology …, 2010 - Wiley Online Library
Plants have been proposed as an attractive alternative for pharmaceutical protein
production to current mammalian or microbial cell‐based systems. Eukaryotic protein …

Cell surface receptors, virus entry and tropism of primate lentiviruses

PR Clapham, Á McKnight - Journal of General Virology, 2002 - microbiologyresearch.org
Human immunodeficiency virus (HIV) exploits cell surface receptors to attach to and gain
entry into cells. The HIV envelope spike glycoprotein on the surface of virus particles binds …